..................... ..................... ..................... ......
The summary displayed below was created by an LLM named 'llama3-8b-8192':
Here is the summary in YAML format:

```
Case Number: 21STCV22952
Hearing Date: February 13, 2024
Dept: 15

People-Names:
  - Rochelle Krich
  - Betty Bell
  - Jacqueline Moline
  - Theresa Emory
  - Richard Kradin
  - John Maddox
  - Gordon
  - Millette
  - Fitzgerald
  - Alice Blount
  - Alice Blount's family members

Company-Names:
  - Johnson & Johnson
  - LTL Management
  - American International Industries

Places:
  - California

Dates:
  - July 8, 2022
  - December 14, 2018
  - April 9, 2019
  - December 3, 2019
  - 2020
  - 2022

Events:
  - Talcum powder use
  - Mesothelioma diagnosis
  - Asbestos contamination
  - Litigation
  - Bankruptcy proceedings
  - FDA symposium
  - Expert testimony

Money:
  - None mentioned

Intentions:
  - To exclude certain evidence and arguments from trial

Facts:
  - Cosmetic talc is FDA-approved
  - FDA does not regulate cosmetic talc
  - Talcum powder has been linked to mesothelioma
  - Johnson & Johnson has been sued in other cases for alleged talcum powder-related injuries
  - LTL Management has been sued in other cases for alleged talcum powder-related injuries

Disputes:
  - Whether Johnson & Johnson and LTL Management knew about the hazards of their talcum powder products
  - Whether the companies concealed the truth about their products
  - Whether the companies' talcum powder products caused mesothelioma and other cancers

Acts:
  - Use of talcum powder
  - Development of mesothelioma
  - Litigation
  - Expert testimony

Agreements:
  - None mentioned

Laws:
  - Federal Food, Drug, and Cosmetic Act
  - California Evidence Code

Case Citations:
  - Bell v. American International Industries, Inc.
  - People v. Veamatahau (2020)

Statutes:
  - Federal Food, Drug, and Cosmetic Act
  - California Evidence Code

Roles:
  - Judge
  - Plaintiff
  - Defendant
  - Expert witness

Significant Statements:
  - "This motion is too vague."
  - "The court cannot predict how this issue could arise at trial."
  - "The motion is granted in part and denied in part without prejudice to objections at trial."
```

Summary:
The tentative ruling addresses 15 motions in limine filed by the plaintiffs and defendants. The court grants some motions and denies others without prejudice to objections at trial. The court excludes certain evidence and arguments, including:

* Evidence about FDA approval of cosmetic talc
* Statements about everyone getting mesothelioma if cosmetic talcum powder causes the disease
* Evidence about other witnesses and attorneys using talcum powder
* References to court orders in other cases about the plaintiffs' experts
* Evidence about talc pleurodesis
* Evidence about Johnson & Johnson's complaints against other individuals
* Media reports about talc litigation
* References to IWGACP formed in 2018 and its 2020-2022 recommendations and papers
* Foreign governmental investigations and proceedings into talcum powder
* Statements that litigation forced defendants to make public the story of asbestos in cosmetic talc
* An article written by Dr. Jacqueline Moline
* A paper authored by Teresa Emory, John Maddox, and Richard Kradin
* Evidence about Alice Blount's testing of Defendants' talc
* References to the Holocaust and conspiracy among defendants and others
* References to the LTL Management bankruptcy proceedings

The court also grants defendants' motions to exclude evidence of other lawsuits against them and to exclude expert testimony that is not reliable. The court denies some motions without prejudice to objections at trial.
